Moneycontrol PRO
Contest Alert:Last day to win Amazon vouchers worth Rs 5000. Take the MCPRO Quiz today to grab yours!

Govt to soon clear Rs 10,000 crore 'Fund of Funds' for MSMEs with high credit rating: Nitin Gadkari

Gadkari said the government wants the Fund's corpus to be utilised by micro, small and medium enterprises (MSMEs) having AAA rating.

April 15, 2020 / 07:50 PM IST
File image: Nitin Gadkari

File image: Nitin Gadkari

A Rs 10,000 crore "Fund of Funds" will soon be approved by the government to buy up to 15 per cent equity in MSMEs with high credit rating that want to list on stock exchanges and raise money from the capital markets, Union Minister Nitin Gadkari said on Wednesday.  He also said a separate scheme was being formulated for according credit rating to MSMEs based on their annual turnover, exports and GST payments, and that the National Small Industries Corporation or another government body will control the Fund of Funds.

He said the government wants the Fund's corpus to be utilised by micro, small and medium enterprises (MSMEs) having AAA rating. The AAA rating implies high credit worthiness.

"We have submitted a proposal for a Fund of Funds of Rs 10,000 crore which has been approved by the Finance Ministry. It is going to be placed before the Cabinet and will soon be cleared," said the minister for MSMEs.

Gadkari said up to 15 per cent of the amount an AAA-rated MSME raises from the capital market will be contributed by the government through the Fund as equity.

The minister said he was expecting Cabinet clearance for the Fund soon and will implement it immediately upon approval.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Interacting with members from the PHD Chamber of Commerce and Industry via video conference, Gadkari exhorted India Inc to also consider the financial condition of the government and banks while placing forth their demands, amid the coronavirus-induced economic crisis.

"The government is also facing a financial crisis. Some state governments do not have enough money to pay salaries to staff next month. The situation of banks is also challenging in terms of their survival," said the minister, emphasising the need to strike an equilibrium to ensure everyone's survival.

Follow our full coverage of the coronavirus pandemic here.
first published: Apr 15, 2020 07:40 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark